Univariate analysis of factors influencing AUC for T-cell subset immune reconstitution
Factor . | P (by 2-tailed t test between mean AUCs) . | |||||
---|---|---|---|---|---|---|
CD4+ T cells . | CD8+ T cells . | |||||
4 m . | 6 m . | 12 m . | 4 m . | 6 m . | 12 m . | |
Age (below median vs above) | .02* | .19 | .05 | .05 | .13 | .17 |
Diagnosis (malignancy vs BMF) | .76 | .54 | .56 | .68 | .70 | .77 |
CD34+ cell dose (above median vs not above) | .59 | .82 | .47 | .84 | .71 | .86 |
CD4+ or CD8+ T-cell dose (above median vs not above) | .32 | .58 | .74 | .19 | .08 | .16 |
aGvHD (grades B-D vs less than grade B)† | .26 | .94 | .39 | .50 | .54 | .63 |
CMV (reactivation vs no reactivation)‡ | .43 | .64 | .88 | .08 | .06 | .005* |
Factor . | P (by 2-tailed t test between mean AUCs) . | |||||
---|---|---|---|---|---|---|
CD4+ T cells . | CD8+ T cells . | |||||
4 m . | 6 m . | 12 m . | 4 m . | 6 m . | 12 m . | |
Age (below median vs above) | .02* | .19 | .05 | .05 | .13 | .17 |
Diagnosis (malignancy vs BMF) | .76 | .54 | .56 | .68 | .70 | .77 |
CD34+ cell dose (above median vs not above) | .59 | .82 | .47 | .84 | .71 | .86 |
CD4+ or CD8+ T-cell dose (above median vs not above) | .32 | .58 | .74 | .19 | .08 | .16 |
aGvHD (grades B-D vs less than grade B)† | .26 | .94 | .39 | .50 | .54 | .63 |
CMV (reactivation vs no reactivation)‡ | .43 | .64 | .88 | .08 | .06 | .005* |